-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Text | Linan
On May 24, the Shanghai Municipal Pharmaceutical Centralized Bidding and Purchasing Affairs Administration issued a public announcement on the verification of the bargained prices of self-financed drugs in Shanghai in 2021 (Phase 1).
The documents show that 11 drugs including Oxiracetam capsules, iron protein succinate oral solution, etazocine hydrobromide injection, doxorubicin hydrochloride liposome injection, sildenafil citrate tablets and other 11 drugs are negotiated.
The Shanghai Pharmaceutical Institute stated that if a pharmaceutical manufacturer has objections to the publicity, it can submit paper appeal materials and affix an official seal (only appeals to the lowest price in five provinces and cities are accepted).
Among them, Baiyunshan Pharmaceutical Factory’s Sildenafil Citrate (50mg×4 tablets/box, aluminum-plastic packaging) and Pfizer’s Sildenafil Citrate (50mg×4 tablets/box, aluminum-plastic packaging) The province where the lowest price of the platform is regulated is Beijing, and the lowest prices are respectively 154 yuan and 409.
It is worth noting that in the third batch of centralized procurement in August last year, four bidders for sildenafil citrate (commonly known as "Viagra") included Pfizer, Baiyunshan, Qilu, and Yabang Epson.
It can be seen that in addition to the national drug procurement, the country is also vigorously promoting the linkage of low drug prices.
The Insight database shows that doxorubicin hydrochloride liposome injection is a special injection formed by encapsulating doxorubicin hydrochloride in PEGylated liposomes by the ammonium sulfate gradient method.
At present, domestic manufacturers of doxorubicin hydrochloride liposome injection include CSPC, Changzhou Jinyuan Pharmaceutical and Fudan Zhangjiang.
In addition, the products that will be removed from the network this time also include the first batch of national key monitoring drugs and local key monitoring drugs, such as creatine phosphate sodium for injection and oxiracetam capsules.
At present, the fifth batch of national centralized procurement of pharmaceuticals is about to debut, and various local centralized procurement alliances are also in full swing.
